<DOC>
	<DOCNO>NCT03035955</DOCNO>
	<brief_summary>The purpose study measure effect azelaic acid Demodex folliculorum count disease condition via split face design approximately twenty patient mild moderate rosacea . The investigator hypothesize treatment rosacea azelaic acid lead decrease Demodex folliculorum count well improvement lesion count redness .</brief_summary>
	<brief_title>Azelaic Acid Demodex Counts Rosacea</brief_title>
	<detailed_description>This split face , randomize , single blind , single center study . Male female ( non-pregnant , non-nursing ) subject , age 18 great , mild moderate papulopustular facial rosacea , bilateral facial involvement , two nodule enrol . Subjects randomize 1:1 study coordinator use standard randomization table receive azelaic acid twice daily either leave side right side face treatment side face . Subjects must positive Demodex folliculorum standardize skin surface biopsy , define &gt; 5 mite cm Screening/Baseline least one two different SSSB specimens bilateral side face . The SSSB test location ideally cheek , may do disease involve area . Subjects see Screening/Baseline , Week 1 Week 4 . Standard topical washout period observe . At visit , rosacea evaluate lesion count , IGA two Demodex SSSB test do side face . Safety monitor visit use Investigator Skin Irritation Assessment .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Male female subject , age 18 , mild moderate paulopustular rosacea bilateral facila involvement , agree participate provide write consent . Positive Demodex folliculorum SSSB , define &gt; 5 mites/cm least two different SSSB specimens bilateral side teh face . Have IGA mild moderate rosacea , rating 2 5 . Use topical therapy rosacea skin condition face within two week Baseline . Use oral medication treatment rosacea start alter within past three month . Presence concurrent medical condition skin condition , determine investigator potentially interfere study outcome patient assessment . Subjects know allergy sensitivity azelaic acid gel component therein , propylene glycol . Subjects know allergy sensitivity cyanoacrylates formaldehyde . Presence two nodule . Female subject postmenopausal least 1 year , surgically sterile willing practice effective contraception study . Reliable method birth control : abstinence , oral contraceptive , intrauterine device , DepoProvera , tubal ligation vasectomy partner monogamous relationship . An acceptable , though less reliable , method involves careful use condom spermicidal foam gel and/or cervical cap sponge . Nursing mother , pregnant woman woman plan become pregnant study exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rosacea</keyword>
	<keyword>Wake Forest</keyword>
	<keyword>Demodex</keyword>
	<keyword>Finacea Gel</keyword>
</DOC>